Search results

Tridentify AB has signed a contract with Intrance Medical Systems regarding the purchase and delivery of the Tridentify Tracer Solution. The Seller (Tridentify AB) has developed an advanced SaaS and IoT system for the real-time monitoring and continuous stability control of pharmaceuticals in the cold chain. The Buyer (Intrance Medical Systems Inc) has developed a drug/device treatment system for patients suffering from Parkinson´s diseases in an advanced stage. The drug component is expected to be delivered internationally and need to be transported under refrigerated conditions. The intended transaction involves the Seller providing the monitoring system as a fee for service, covering safeguarding services of shipments of the pharmaceutical products used in the Buyer´s clinical development program including clinics in the EU and the US. -  Tridentify is delighted about the interest that Intrance Medical Systems has shown in our Tracer Solution. We are proud that Intrance is to become our first signed biomedical customer and that we will be able to support the development of a new Parkinson treatment in the US, says Johan Stormlund, CEO at Tridentify. About Tridentify AB Tridentify is a Swedish Software-as-a-Service MedTech company that helps customers control the entire supply chain and cold chain logistics for transfusion medicine blood, plasma and other temperature-sensitive goods. After further development work, we can now provide our unique system to the entire spectrum of sensitive and expensive biomedicine. Our safeguarding Tracer System accurately measures temperature and condition, throughout the life cycle of biological and pharma products. Unlike all other solutions, the Tracer System® is programmed to the exact specifications of the medicine. This gives it the ability to communicate the shelf life of the actual individual package it is attached to in real time. With Tridentify's SaaS/IoT system, the costs of delivery audits are reduced. There is significantly less wastage and less destroyed biopharma. Our technology makes it safer and easier to comply with current and future legislation and medical requirements. Finally, and most importantly, we increase the safety for the patient who can trust that the Biopharma fulfills its function. For more information, visit tridentify.com About Intrance Medical Systems Inc Intrance Medical Systems, Inc., a subsidiary of Sweden-based Intrance Holdings AB, is a private biopharmaceutical company focused on the development and commercialization of its lead clinical product for the treatment of advanced Parkinson’s disease in the U.S., Canada, South America, Japan and Taiwan. For more information, visit intrancemedical.com

Tridentify's recent participation in the highly anticipated ISB 2023 in Gothenburg was an enormous success! As one of the event's proud sponsors, we had the opportunity to showcase our revolutionary temperature monitoring system and connect with industry professionals from around the world. Representatives from various countries and diverse backgrounds visited our booth, providing us with a global perspective and reinforcing the importance of our temperature monitoring solution on an international scale. We had the privilege of engaging in meaningful discussions, exchanging insights, and exploring potential collaborations with industry leaders, healthcare professionals, and decision-makers. For those who couldn't attend ISB 2023, don't worry! We are committed to keeping you updated on the latest advancements in our temperature monitoring system and its successful implementations. Stay tuned to our social media channels, and website, for informative content, product updates, and testimonials from satisfied customers.

Tridentify looks forward to sponsoring and attending the 33rd ISBT congress in Gothenborg, June 17-21st. Come visit us at our booth #2927, and learn more about how our customers are saving up to 90% of their waste by using our temperature monitoring system.

Tridentify, a leading provider of supply chain monitoring and management solutions, is excited to announce the launch of their latest product – a real-time monitoring system for temperature-sensitive shipments that include GPS geo-tracking and real-time calculation of remaining stability budget. This new monitoring system provides an all-in-one solution for tracking temperature-sensitive shipments, providing users with real-time data on the location and temperature of their products. With GPS geo-tracking, customers can follow their shipments from start to finish, ensuring that they are delivered to the right location at the right time. The real-time calculation of remaining stability budget provides an additional layer of protection, reducing waste and increasing patient safety by ensuring that the products are stored at the correct temperature throughout the entire supply chain. "We are thrilled to launch this new monitoring system, which provides our customers with the ability to track their temperature-sensitive shipments in real-time, including GPS geo-tracking and real-time calculation of remaining stability budget," said Johan Stormlund, CEO of Tridentify. "This is a game-changer for the industry, as it will help our customers to reduce waste, increase patient safety and ultimately save lives."

Come join our roundtable session at Logipharma 2023. The topic is: Taking QA decisions in realtime based on algorithms". Join us as we discuss real time decision-making with Mr Johan Stormlund (Thought leader), CEO, Tridentify, Mr Tomas Fant (Co-leader), Pfizer, Temperature Controlled Logistics Projects Lead and Mr Brett Marshall (Co-leader), Zuellig Pharma, Corporate Head, Quality.Tuesday 25th April, at 15:25, Track C – Mastering Temperature Controlled Operations.Welcome!

Tridentify is a proud sponsor of Logipharma 2023. The event will be held in Lyon, France 25-27th April. I´m looking forward to meeting you all there. And I can promise we will have some exciting news to share during the event.

EU is about to update and reinforce the rules within the handling of blood, tissues and cells. This is to ensure quality and patient safety. Read more here: https://ec.europa.eu/commission/presscorner/detail/en/QANDA_22_4404 Tridentify is the only Medical Device approved temperature monitoring system, that will support future requirements. We need to end the wasting of both blood and pharmaceuticals!Contact Tridentify to get more information on how we can support decreasing your waste.

Tridentify is sponsoring the Nordic QA forum that will take place on 24th November, 2022. The conference is held at Clarion Copenhagen Airport, Denmark. Come visit our booth.

Watch this video and view how Tridentify temperature monitoring solution can be used for full end2end visibility in your supply chain.

Come and visit our booth #7 at the TCL conference in Düsseldorf, 7-9th June, 2022.

Save blood - Save lives.

Tridentify started as a public hospital commissioned project with a simple goal: to find a way of monitoring the temperature of a blood bag from vein to vein to waste less blood. This is something Interregional Blood Transfusion SRC Ltd.in Switzerland have been very successful doing. Since end of year 2020 they have been using the temperature monitoring system from Tridentify AB. The difference between Tridentify´s system and competitors’ system are that Tridentify´s system not only monitor the temperature, but it also monitoring remaining shelf-life in real-time. This will start to create Cost savings. Monika Finger, Distribution Manager at Interregional Blood Transfusion SRC says:” We use the Tracers on blood bags to monitor the temperature when they are outside the cold storage. For the blood bags not used we read out the temperature, and if the system shows there are remaining shelf-life, the blood bags can be saved for future use.” The blood bags are normally stored in +2C to + 6C in maximum 42 days. But can be for a limited time in temperature even up to +15C. As the Tridentify´s system calculates remaining shelf life when the blood bags are exposed to higher temperatures, the system will give an OK if blood bag can be placed back in the cold store instead of going to waste. Monika Finger says: “Last year we saved approximately 350 blood bags. The value for one blood bag is = 233 CHF”. This means that annually they are saving blood for a value = 80.000 CHF. These savings are of course reduced by the operating costs but are still in positive territory. “It´s not only about the money saved. There is often a low stock of blood. Every single bag of blood we can save can help ensure the supply for the patients (in the hospitals)", says Monika.